Terbizor

Terbizor Tablets.

Terbinafine

BRYON PHARMACEUTICALS (PVT) LTD.

Drug Identity

Active Ingredient
Terbinafine
Drug Class
Antimycotics Systemic Use
Chemical Class
Antifungal Agent pharmacological group
ATC Code
D01AE15, D01BA02
Status
Essential Medicine

What is Terbizor?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How It Works

Chemical Class
Antifungal Agent pharmacological group

It is of Synthetic origin. It belongs to Antifungal Agent pharmacological group.

How to Take It

1
Adult · PO
250 mg — 24 hourly
2
Adult · Topical
1 % — 12 hourly
For 1-2 Weeks
3
Child
Not recommended in this age group

Safety Alerts

Hypersensitivity to terbinafine

Important Warnings

Autoimmune disease (risk of lupus erythematosus-like effect), psoriasis (risk of exacerbation), chronic liver dysfunction or impaired renal function

Side Effects

Taste disturbanceGI disturbanceabdominal discomfortanorexiaarthralgiadiarrhoeadyspepsiaheadachemyalgianausearashurticaria. Rare: Cholestasisdizzinesshepatitishypoaesthesia

Drug Interactions

Cyclosporin
tolbutamide
oral contraceptives
rifampicin
cimetidine.

Pregnancy & Lactation

Pregnancy
Caution advised, avoid
Lactation
Contraindicated, avoid

Storage

Cream Store Below 40°C. Protect from Sunlight and Heat. Tab, Cream Store Between 15°C-25°C. Protect from Sunlight and Heat.

Price Intelligence

Rs 464.43
DRAP approved maximum price · per pack of 10 · approved 11 Aug, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 10Rs 464.43

Should you consider an alternative?

Other options containing Terbinafine, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.